Compare SID & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SID | AXGN |
|---|---|---|
| Founded | 1941 | N/A |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2002 | 2013 |
| Metric | SID | AXGN |
|---|---|---|
| Price | $1.28 | $33.30 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $1.40 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 7.6M | 742.6K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $2.38 | $20.31 |
| Revenue Next Year | $2.49 | $16.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $1.11 | $9.22 |
| 52 Week High | $2.20 | $36.00 |
| Indicator | SID | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 43.68 | 56.37 |
| Support Level | N/A | $30.34 |
| Resistance Level | $1.64 | $34.25 |
| Average True Range (ATR) | 0.06 | 1.41 |
| MACD | 0.02 | 0.22 |
| Stochastic Oscillator | 84.21 | 79.15 |
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.